Biological Intellectual Property Protection Act of 2025

Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 30 - 14.

2026-04-22

This bill would establish protections for biological materials and genetic information developed by American researchers and companies, likely preventing other countries from using or profiting from U.S. biological innovations without permission. The legislation aims to strengthen international agreements and enforcement mechanisms to ensure American scientists and biotech firms maintain control over their discoveries in areas like medicine, agriculture, and biotechnology. It affects researchers, pharmaceutical companies, agricultural businesses, and the U.S. government's ability to negotiate trade deals involving biological resources.